Major Molecular Response Achievement in CML Patients Can Be Predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS Ratio at an Earlier Time Point of Follow-Up than Currently Recommended

Recent studies demonstrate that early molecular response to tyrosine-kinase inhibitors is strongly predictive of outcome in chronic myeloid leukemia patients and that early response landmarks may identify patients at higher risk for transformation who would benefit from an early switch to second-lin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Huet, Sarah, Cony-Makhoul, Pascale, Heiblig, Maël, Tigaud, Isabelle, Gazzo, Sophie, Belhabri, Amine, Souche, Denis, Michallet, Mauricette, Magaud, Jean-Pierre, Hayette, Sandrine, Nicolini, Franck
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2014
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4159116/
https://ncbi.nlm.nih.gov/pubmed/25203717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0106250
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars